Type to select a Country
Introduction of new or underutilized vaccines in low- and middle-income countries.
The target is 500 vaccine introductions in low- and middle-income countries by 2030, including current new or under-utilized vaccine introductions (NUVI) as well as vaccines that will be recommended over the decade. Progress will be evaluated annually.
Introduction of new or underutilized vaccines in low- and middle-income countries—Global
Target: At least
500
cumulative vaccine introductions in low- and middle-income countries by 2030
Vaccine introductions | 2020 | 2021 |
---|---|---|
Total | 28 | 167 |
Covid | 4 | 127 |
DTP Booster | 0 | 2 |
HepB BD | 1 | 0 |
HiB | 0 | 0 |
HPV | 4 | 5 |
IPV2 | 4 | 17 |
PCV | 2 | 5 |
Rotavirus | 4 | 4 |
Rubella | 0 | 0 |
Cholera | 0 | 0 |
Hep A | 1 | 0 |
Influenza | 5 | 3 |
JE | 0 | 0 |
MenA | 0 | 1 |
Multivariant Men | 0 | 0 |
Mumps | 1 | 0 |
Rabies | 0 | 0 |
Typhoid | 0 | 0 |
Varicella | 0 | 0 |
Yellow Fever | 0 | 0 |
MCV2 | 2 | 3 |
New or underutilized vaccines are defined as vaccines that have not yet been introduced into national immunization schedules in all countries where recommended by WHO.